Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Nakamura Y, Mori K, Enomoto Y, Kono M, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Nakamura H, Hayakawa H, Suda T. Nakamura Y, et al. Among authors: koshimizu n. J Clin Med. 2021 Apr 4;10(7):1498. doi: 10.3390/jcm10071498. J Clin Med. 2021. PMID: 33916508 Free PMC article.
Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD).
Suda T, Kono M, Nakamura Y, Enomoto N, Kaida Y, Fujisawa T, Imokawa S, Yasuda K, Hashizume H, Yokomura K, Toyoshima M, Koshimizu N, Suganuma H, Shirai T, Hashimoto D, Inui N, Colby TV, Chida K. Suda T, et al. Among authors: koshimizu n. Respir Med. 2010 Oct;104(10):1527-34. doi: 10.1016/j.rmed.2010.04.022. Epub 2010 May 18. Respir Med. 2010. PMID: 20483576 Free article.
Prognostic factors for myositis-associated interstitial lung disease.
Fujisawa T, Hozumi H, Kono M, Enomoto N, Hashimoto D, Nakamura Y, Inui N, Yokomura K, Koshimizu N, Toyoshima M, Shirai T, Yasuda K, Hayakawa H, Suda T. Fujisawa T, et al. Among authors: koshimizu n. PLoS One. 2014 Jun 6;9(6):e98824. doi: 10.1371/journal.pone.0098824. eCollection 2014. PLoS One. 2014. PMID: 24905449 Free PMC article.
Phase II study of erlotinib in elderly patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
Inoue Y, Inui N, Asada K, Karayama M, Matsuda H, Yokomura K, Koshimizu N, Imokawa S, Yamada T, Shirai T, Kasamatsu N, Suda T. Inoue Y, et al. Among authors: koshimizu n. Cancer Chemother Pharmacol. 2015 Jul;76(1):155-61. doi: 10.1007/s00280-015-2784-x. Epub 2015 May 24. Cancer Chemother Pharmacol. 2015. PMID: 26003540 Clinical Trial.
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer.
Kusagaya H, Inui N, Karayama M, Fujisawa T, Enomoto N, Kuroishi S, Nakamura Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Suda T. Kusagaya H, et al. Among authors: koshimizu n. Lung Cancer. 2015 Dec;90(3):410-6. doi: 10.1016/j.lungcan.2015.11.009. Epub 2015 Nov 7. Lung Cancer. 2015. PMID: 26791800 Clinical Trial.
Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer.
Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, Yokomura K, Koshimizu N, Sato M, Toyoshima M, Shirai T, Masuda M, Yamada T, Imokawa S, Suda T. Karayama M, et al. Among authors: koshimizu n. Eur J Cancer. 2016 May;58:30-7. doi: 10.1016/j.ejca.2016.01.013. Epub 2016 Feb 27. Eur J Cancer. 2016. PMID: 26922170 Clinical Trial.
44 results